Daniel J. George, M.D.

Duke Cancer Center

Director of Genitourinary Oncology

Medical Oncologist

Daniel George, MD | Kidney Cancer Research Consortium
Dr. Daniel J. George, MD, is a distinguished Medical Oncologist at Duke University, specializing in the comprehensive care of patients with urologic cancers, with a primary focus on prostate, kidney, bladder, and testicular cancer. Dr. George prioritizes providing a profound understanding of each patient’s case and presenting viable options, instilling knowledge as a source of reassurance and empowerment.


Education & Training:

Medical Oncology, Johns Hopkins Hospital (Maryland), 1995-1998
Internal Medicine, Johns Hopkins Hospital (Maryland), 1992-1995
MD, Duke University School of Medicine, 1992


Current Appointments and Affiliations:

Eleanor Easley Distinguished Professor in the School of Medicine, Medicine, Medical Oncology 2023
Professor of Medicine, Medicine, Medical Oncology 2015
Professor in Surgery, Surgery 2015
Member of the Duke Cancer Institute, Duke Cancer Institute 2003


Professional Accomplishments:

As the leader of a robust clinical research team at Duke, Dr. George has significantly contributed to advancing therapeutic approaches and enhancing care outcomes for patients with urologic cancers. His research portfolio spans interventional trials involving novel therapies, diagnostic tests, and markers delving into cancer biology, response, and overall outcomes. Driven by a keen interest in immuno-oncology agents and targeted therapies, his work embodies a commitment to pioneering advancements in cancer treatment.

Leadership and Impact:

Dr. George’s research extends beyond conventional boundaries, exploring lifestyle interventions and support mechanisms to improve the overall cancer experience for patients. His team’s dedication is evident in the inclusion of diverse professionals fostering a multidisciplinary approach to cancer care. With a notable proportion of African American patients under his care, Dr. George places a particular emphasis on understanding the unique aspects of their diseases and strives to enhance care delivery for this population.

Dr. George distinguishes himself through his personal approach, fostering trust with patients through genuine care and unwavering expertise. His relentless pursuit of knowledge and innovation underscores his commitment to transforming the landscape of urologic cancer care, making him an invaluable asset to both Duke University and the broader medical community.

“When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case.”

Naomi Haas, MD | Kidney Cancer Research Consortium

Naomi Haas


Hans Hammers

UT Southwestern

Eric Jonasch, M.D. | Kidney Cancer Research Consortium

Eric Jonasch

MD Anderson

David McDermott, MD | Kidney Cancer Research Consortium

David McDermott

Beth Israel

Brian Rini, MD | Kidney Cancer Research Consortium

Brian Rini

Vanderbilt University

Ulka Vaishampayan, MD | Kidney Cancer Research Consortium

Ulka Vaishampayan

University of Michigan